Investors & Media

Investor Contacts

35 Gatehouse Dr.
Waltham, MA 02451
IR@entasistx.com

"Antibiotic resistance is a worldwide problem that is constantly growing. New forms of resistance can spread quickly and across continents. At Entasis, we discover and develop novel antibacterials to address the serious medical need posed by multi-drug resistant bacterial infections."

— Ruben Tommasi, Chief Scientific Officer